Chemkart India IPO

Incorporated in 2015, Chemkart India Limited is a distributor specializing in high-quality food and health ingredients. The company bridges the gap between global ingredient manufacturers and businesses across various sectors. The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Focused on variety, affordability, quality, and customer relationships, it enhances supply chain processes. The company provides grinding, blending, and packaging services at its hygienic facility in Bhiwandi, Mumbai. The 28,259.16 sq. ft. warehouse is equipped for efficient processing, labeling, and sealing of ingredients. Products Portfolio: Amino Acid: The Building blocks of proteins essential for biological processes and metabolism. Health Supplement: Supplements with essential nutrients and bioactive compounds for wellbeing. Herbal Extract: Extracts from plants used for therapeutic and functional benefits. Nucleotide: Key components supporting immune health, gut health, and nutrition. Protein: Vital for muscle growth, immune function, and overall health. Sports Nutrition: Ingredients supporting athletic performance, endurance, and recovery. Vitamins: Micronutrients essential for various bodily physiological functions. As of March 31, 2025, the company had 40 employees. Competitive Strengths: Diversified product portfolio In house processing and warehousing capabilities Value proposition for Customers

The Company Chemkart India IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (₹ in crores) 1 Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited 34.68 2 Repayment/prepayment of all or certain of the borrowings availed of by the Company 20.00 3 General Corporate Purpose

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App